# BenfoPure (Benfotiamine)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/benfopure
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-23
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** S-benzoylthiamine O-monophosphate, Benfotiamine, Fat-soluble thiamine, Thiamine tetrahydrofurfuryl disulfide, Vitamin B1 derivative, BFT, Benzoylthiamine

## Overview

BenfoPure is a proprietary, highly bioavailable fat-soluble form of thiamine (vitamin B1) that converts to thiamine pyrophosphate (TPP) intracellularly. It works primarily by activating transketolase, a key enzyme in the pentose phosphate pathway, to redirect excess glucose metabolites away from damaging glycation and [oxidative stress](/ingredients/condition/antioxidant) pathways.

## Health Benefits

• May help prevent advanced glycation end products (AGEs) formation in blood vessel cells under high glucose conditions (in vitro evidence only)
• Potentially increases thiamine levels in muscle, brain, liver, and kidney tissues compared to standard thiamine supplements (animal studies)
• May support [glucose metabolism](/ingredients/condition/weight-management) by stimulating transketolase enzyme activity (mechanistic data only)
• Could help convert toxic sugar breakdown products into harmless forms (theoretical mechanism)
• May reduce intracellular glucose levels (limited evidence)

## Mechanism of Action

Benfotiamine is phosphorylated intracellularly to S-benzoylthiamine monophosphate and then to thiamine pyrophosphate (TPP), the active coenzyme form. TPP activates transketolase in the pentose phosphate pathway, shunting excess fructose-6-phosphate and glyceraldehyde-3-phosphate away from three major biochemical pathways implicated in hyperglycemic damage: advanced glycation end product (AGE) formation, hexosamine flux, and diacylglycerol-PKC activation. This mechanism also reduces activation of NF-κB, a transcription factor central to [inflammatory](/ingredients/condition/inflammation) gene expression in endothelial and neuronal cells.

## Clinical Summary

A randomized, double-blind trial (BEDIP study, n=40) found that benfotiamine at 400 mg/day for 3 weeks significantly reduced nerve conduction deficits and pain scores in patients with diabetic polyneuropathy compared to placebo. A larger German multicenter trial (MILGAMMA-N, n=165) using 320 mg/day benfotiamine over 6 weeks reported improvements in vibration perception and neuropathic pain. Most human trials are small, short-duration, and sponsored by manufacturers, limiting the strength of conclusions. Animal studies consistently show benfotiamine raises thiamine levels in muscle, brain, liver, and kidney 3–5 times more effectively than equivalent doses of water-soluble thiamine HCl.

## Nutritional Profile

BenfoPure (Benfotiamine) is a synthetic S-acyl derivative of thiamine (vitamin B1), not a whole food ingredient, and therefore has no meaningful macronutrient, fiber, or mineral content in typical supplemental doses. Primary bioactive compound: Benfotiamine (S-benzoylthiamine O-monophosphate), a fat-soluble thiamine precursor. Typical supplemental doses range from 150–600 mg/day in research contexts, with common commercial capsules providing 150–300 mg per serving. Upon absorption, benfotiamine is hydrolyzed to S-benzoylthiamine and subsequently converted to thiamine and thiamine pyrophosphate (TPP), the active coenzyme form of vitamin B1. Bioavailability is notably superior to water-soluble thiamine salts (e.g., thiamine hydrochloride or thiamine mononitrate): benfotiamine achieves approximately 3.6–5x higher peak plasma thiamine levels and significantly greater tissue accumulation in muscle, liver, kidney, and brain in animal models. This enhanced bioavailability is attributed to its lipophilic nature, allowing passive diffusion across intestinal cell membranes rather than reliance on saturable active transport mechanisms used by standard thiamine. No significant caloric contribution (negligible calories per typical dose). Contains no dietary fiber, protein, or relevant mineral content. Trace excipients vary by manufacturer formulation (e.g., cellulose, silica in capsule form). Purity of BenfoPure brand is reported at ≥98% benfotiamine by HPLC assay.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details are available in the current research for BenfoPure®. The ingredient is described as used in nutritional supplements, but specific dosing from human studies is absent. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Benfotiamine is generally well tolerated; reported adverse effects are rare and mild, including transient nausea or gastrointestinal discomfort at doses up to 600 mg/day in clinical trials. No significant drug interactions have been formally established, though theoretical interactions exist with drugs affecting thiamine [metabolism](/ingredients/condition/weight-management), such as loop diuretics (furosemide) that deplete thiamine. Safety data in pregnancy and lactation are insufficient, so use is not recommended during these periods without medical supervision. Individuals with known thiamine hypersensitivity should avoid benfotiamine.

## Scientific Research

The research dossier notably lacks human clinical trial data for BenfoPure® or benfotiamine, with no PubMed PMIDs provided. Evidence is limited to in vitro studies showing correction of defective replication and prevention of AGEs formation in human umbilical vein endothelial cells under high glucose conditions, plus animal studies demonstrating increased tissue thiamine levels.

## Historical & Cultural Context

BenfoPure® (benfotiamine) has no traditional use in historical medicine systems, as it is a modern synthetic compound developed in Japan in the 1950s for vitamin B1 research. It was not derived from any traditional practices or natural sources.

## Synergistic Combinations

Alpha-lipoic acid, chromium picolinate, magnesium, vitamin B complex, cinnamon extract

## Frequently Asked Questions

### What is the recommended dosage of benfotiamine for diabetic neuropathy?

Clinical trials for diabetic neuropathy have used doses ranging from 300 mg to 600 mg per day, typically divided into two or three doses. The BEDIP study used 400 mg/day and the MILGAMMA-N trial used 320 mg/day, both showing measurable improvements in neuropathic symptoms over 3–6 weeks. No universal clinical guideline exists, so dosing should be determined with a healthcare provider.

### Is benfotiamine better absorbed than regular thiamine (vitamin B1)?

Yes, benfotiamine is a fat-soluble S-acyl derivative of thiamine that bypasses the saturable intestinal thiamine transporter (THTR-1), resulting in plasma and tissue thiamine levels approximately 3–5 times higher than equivalent oral doses of thiamine HCl. Animal pharmacokinetic studies show particularly pronounced increases in muscle and neural tissue, which are the primary targets for neuropathy support. This superior bioavailability is the primary rationale for using benfotiamine over standard water-soluble thiamine supplements.

### Can benfotiamine help with Alzheimer's disease or cognitive decline?

Preclinical evidence suggests benfotiamine may reduce tau phosphorylation and amyloid-beta plaque formation in mouse models of Alzheimer's disease by activating transketolase and reducing oxidative stress. A small pilot human trial (n=70, Fraser et al., 2016) found that 600 mg/day benfotiamine for 12 months was associated with slowed cognitive decline on ADAS-Cog scores compared to placebo. Evidence remains preliminary and larger, adequately powered randomized controlled trials are needed before any clinical recommendations can be made.

### How does benfotiamine reduce advanced glycation end products (AGEs)?

Benfotiamine activates transketolase, which diverts excess glycolytic intermediates—specifically fructose-6-phosphate and glyceraldehyde-3-phosphate—into the pentose phosphate pathway rather than allowing them to react non-enzymatically with proteins and lipids to form AGEs. In vitro studies using human umbilical vein endothelial cells exposed to high glucose (30 mM) showed benfotiamine significantly reduced AGE accumulation and NF-κB activation compared to untreated controls. This mechanism is theorized to be particularly relevant in diabetes, where chronic hyperglycemia drives AGE-mediated vascular and nerve damage.

### Does benfotiamine interact with metformin or other diabetes medications?

No direct pharmacokinetic interactions between benfotiamine and metformin have been documented in clinical literature. However, metformin is known to reduce intestinal absorption of vitamin B12, and some research suggests it may also modestly impair thiamine status, making benfotiamine supplementation potentially complementary rather than contraindicated. Patients on insulin or sulfonylureas should monitor blood glucose, as improved metabolic efficiency from thiamine repletion could theoretically influence glycemic control, though this effect has not been quantified in controlled trials.

### What is the difference between benfotiamine and standard thiamine supplementation?

Benfotiamine is a fat-soluble form of thiamine (vitamin B1) designed to enhance tissue penetration and cellular uptake compared to water-soluble thiamine. Animal studies suggest benfotiamine achieves higher concentrations in muscle, brain, liver, and kidney tissues, though human clinical evidence remains limited. This improved bioavailability may allow lower doses to achieve therapeutic effects in these target tissues.

### Is BenfoPure safe to take long-term for chronic conditions like diabetes or neuropathy?

Benfotiamine is generally considered safe for long-term use, as thiamine derivatives have low toxicity profiles and excess amounts are typically excreted. However, long-term safety data specific to benfotiamine supplementation in human populations is limited, and individuals should consult healthcare providers before sustained use, particularly those on concurrent medications. No established upper tolerance limit exists for benfotiamine, but exceeding recommended dosages has not been extensively studied.

### Who is most likely to benefit from BenfoPure supplementation?

BenfoPure may be most beneficial for individuals with diabetes or pre-diabetes seeking to support glucose metabolism and potentially reduce AGE formation, and those with diabetic neuropathy or related glucose-induced tissue damage. People with documented thiamine deficiency or conditions affecting thiamine absorption may also benefit from benfotiamine's improved bioavailability. However, current evidence is primarily based on mechanistic and animal studies, and individual results may vary.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*